MedTrace Logo

Evaluation of Metabolism-Boosting Beverages

NCT01029236 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2009-12-09

No results posted yet for this study

Summary

The purpose of this study is to assess the effect of Metabolism-boosting Beverages (MBB) containing green tea extract with a standardized amount of epigallocatechin gallate (EGCG) and caffeine.

Conditions

  • Energy Expenditure
  • Appetite

Interventions

OTHER

Medifast Metabolism-boosting Beverages

Medifast metabolism-boosting beverages containing 90 mg EGCG and 100 mg caffeine.

Sponsors & Collaborators

  • Medifast, Inc.

    lead INDUSTRY

Principal Investigators

  • Lisa M Davis, PhD, PA-C · Medifast, Inc.

  • Christopher D Coleman, MS,RD,LDN · Medifast, Inc.

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01029236 on ClinicalTrials.gov